Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill tested for tough blood cancers

NCT ID NCT04756726

Summary

This early-stage study is testing a new oral drug called CFT7455 (cemsidomide) for people with non-Hodgkin's lymphoma or multiple myeloma that has come back or stopped responding to other treatments. The main goals are to find a safe dose and see if the drug helps shrink tumors. The drug is taken by mouth, sometimes with another medication called dexamethasone for myeloma patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Colorado Blood Cancer Institute (Sarah Cannon Research Institute)

    Denver, Colorado, 80218, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Emory University Hospital

    Atlanta, Georgia, 30322, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Mayo Clinic

    Phoenix, Arizona, 85054, United States

  • Mayo Clinic

    Jacksonville, Florida, 32224, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Mt Sinai Medical Center

    New York, New York, 10029, United States

  • Tennessee Oncology (Sarah Cannon Research Institute)

    Nashville, Tennessee, 37203, United States

  • University of California-San Francisco

    San Francisco, California, 94143, United States

  • Washington University School of St. Louis

    St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.